Abstract
(Int J Obstet Anesth. 2015;24(4):313–322) Two popular techniques for the treatment of labor pain are epidural analgesia (EA) and intravenous remifentanil patient-controlled analgesia (RPCA). Remifentanil is a μ-opioid receptor agonist with a rapid onset of action and short latency to peak analgesic effect. This randomized, controlled trial was performed to compare the rate of maternal fever (temperature ≥38°C) in parturients receiving RPCA with those receiving either EA or no analgesia. The authors hypothesized that fever would be more prevalent in patients receiving EA compared with patients receiving either RPCA or no analgesia. The secondary objectives studied included differences in maternal oxygen saturation (SpO2), nausea, vomiting, sedation, pruritus, hypotension, and neonatal outcome.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
